Why Sean Parker Took on Cancer: Funding Risk, Failure, and Real Progress

Most people know Sean Parker as the prodigy behind Napster and Facebook. Far fewer know why he chose to take on one of the hardest problems in science: cancer. In this clip from Precision Signals, we explore the founding insight behind the Parker Institute for Cancer Immunotherapy—that the greatest barrier to progress in cancer research isn’t talent or ideas, but how science is funded. Despite more than $300 billion spent on cancer R&D in the U.S. alone, progress has been slowed by systems that reward safety, incrementalism, and short-term wins—rather than bold, high-risk, potentially curative science. In conversation with Karen Knudsen, CEO of the Parker Institute, we unpack why embracing risk and accepting failure aren’t flaws in science—they’re prerequisites for real breakthroughs.